Pernix Therapeutics Announces Successful Closing of Transaction Regarding Worldwide Rights to Contrave® for Weight Loss

Stock Information for Pernix Therapeutics Holdings Inc - Ordinary Shares

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Pernix Therapeutics Holdings Inc - Ordinary Shares

Pernix Therapeutics Holdings, Inc. Enters into Asset Purchase Agreement with Certain Funds Managed by Highbridge Capital Management
Detailed Research: Economic Perspectives on Pernix Therapeutics, Hallador Energy, Vince Holding, Tuesday Morning, Information Services Group, and Sienna Biopharmaceuticals - What Drives Growth in Today's Competitive Landscape
Pernix® Therapeutics Reports Third Quarter 2018 Financial Results
Pernix Therapeutics to Report Third Quarter 2018 Financial Results on Thursday, November 8
Pernix Therapeutics Holdings, Inc.'s Subsidiaries File Notice of Appeal in Patent Litigation Concerning Zohydro® ER with BeadTek®
Pernix Therapeutics Announces Ruling in Patent Litigation Concerning Zohydro® ER with BeadTek®
Pernix Therapeutics Reports Second Quarter 2018 Financial Results
Pernix Therapeutics Announces a Series of Transactions to Strengthen Its Balance Sheet and Improve Financial Flexibility

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.